DSIP dosage calculator
Enter a vial and a dose and this returns the concentration, the volume and the syringe units. Underneath it, the same arithmetic worked out in advance for common vials, and the doses published studies of DSIP actually used, every one quoted and cited. It converts numbers. It does not suggest what to take.
Work out concentration and what to draw
Two divisions, both shown. Concentration = mass in the vial ÷ diluent volume. Volume to draw = mass you want ÷ that concentration. Syringe units are that volume × the units per millilitre on your syringe's own scale.
Worked example: 5 mg in 2 mL is 2,500 mcg/mL, so 250 mcg is 0.1 mL, which is 10 units on a U-100 syringe and 4 units on a U-40. The scale is printed on the barrel; reading a U-40 syringe as if it were U-100 is a two-and-a-half-fold error.
DSIP reconstitution chart
Units on a standard U-100 insulin syringe, where 100 units is 1 mL. The rows are the absolute doses quoted in studies of DSIP, from 300 mcg to 4 mg, so this chart is specific to this compound rather than a generic ladder. More diluent means more units for the same dose, which is easier to measure accurately and empties the vial no faster.
| Dose | 1 mL diluent (2,000 mcg/mL) | 2 mL diluent (1,000 mcg/mL) | 3 mL diluent (667 mcg/mL) |
|---|---|---|---|
| 300 mcg | 15 | 30 | 45 |
| 1.5 mg | 75 | 150 >1 mL | 225 >1 mL |
| 4 mg | 200 >1 mL | 400 >1 mL | 600 >1 mL |
| Dose | 1 mL diluent (5,000 mcg/mL) | 2 mL diluent (2,500 mcg/mL) | 3 mL diluent (1,667 mcg/mL) |
|---|---|---|---|
| 300 mcg | 6 | 12 | 18 |
| 1.5 mg | 30 | 60 | 90 |
| 4 mg | 80 | 160 >1 mL | 240 >1 mL |
| Dose | 1 mL diluent (10,000 mcg/mL) | 2 mL diluent (5,000 mcg/mL) | 3 mL diluent (3,333 mcg/mL) |
|---|---|---|---|
| 300 mcg | 3 | 6 | 9 |
| 1.5 mg | 15 | 30 | 45 |
| 4 mg | 40 | 80 | 120 >1 mL |
Read a figure off this chart only if it matches the vial in front of you. A vial labelled a different strength, or reconstituted with a different volume, gives a different number for the same dose, and that is the single most common way these calculations go wrong.
Doses in published studies of DSIP
Each row is quoted from a paper in this compound's source ledger and carries the kind of evidence it came from. 5 of 5 come from human studies; the rest are animal or laboratory work.
| Evidence | Dose as the paper states it | Source |
|---|---|---|
| Human clinical trial | Every controlled sleep trial infused 25 nanomoles per kilogram of body weight intravenously, about 21 micrograms per kilogram or roughly 1.5 mg for a 70 kg adult. | pmid-3583493 |
| Human clinical trial | Sixteen chronic insomniacs received 25 nmol/kg intravenously in the afternoon before three consecutive nights. | pmid-1299794 |
| Human clinical trial | Total intravenous doses of 3 and 4 mg were infused over two hours around a CRH challenge in healthy young men. | pmid-7777652 |
| Observational, human | In withdrawal patients, 25 nmol/kg was injected intravenously as the sole treatment. | pmid-6328354 |
| Human clinical trial | A Russian DSIP preparation, deltalicin, was given intranasally at 0.3 mg a day to patients with diabetic retinopathy. | pmid-25739189 |
Weight-normalised doses, and why they are not on the chart
Some studies state a dose per kilogram. Those figures are deliberately absent from the chart above, because multiplying one by a body weight produces a number that looks like a dose and is not one. Interspecies scaling is not arithmetic: a rat milligram-per-kilogram figure does not become a human dose by multiplication.
- 25 nmol/kg intravenous, the dose in every controlled sleep trial and the hormone studies. pmid-7698722
- Animal study, rats, 2007: weight-normalized doses as published: 1.0 mg/kg. For the purpose of the study, valproate in the doses of 50 or 75 mg/kg and DSIP (1.0 mg/kg) was i.p. injected either alone or in combination to adult Wistar male rats with fully developed metaphit seizures after eight audiogenic testing. pmid-17957464
How long studies ran, and how far a vial goes
A vial lasts for a number of draws, not a number of weeks: divide the mass in the vial by the mass per draw and round down, which the vial planner does. How long that represents depends on frequency. For context, these are the durations studies of DSIP actually ran for.
- Seven consecutive nights of infusion, with polysomnography at baseline, start, end and one post-treatment night. pmid-3622582
- Four nights, crossover. pmid-3583493
- Three treatment nights after two laboratory nights of adaptation and baseline. pmid-1299794
- A single dose, with plasma sampled for hours afterwards. pmid-2554357
- Animal study, rats, 2021: durations stated: 8 days. Background and Objectives : Mutual effect of the preliminary and therapeutic intranasal treatment of SD rats with DSIP (8 days) on the outcome of focal stroke, induced with intraluminal middle cerebral occlusion (MCAO), was investigated. pmid-34500605
Storage and stability, as published
Reconstitution starts a clock. These are the storage and stability conditions stated in papers in this ledger. They describe what the study did, which is not the same as a shelf life for a vial in your fridge.
- Animal study, rats, 2005: Activity of enzymes catalyzing synthesis and degradation of serotonin and dopamine in brain structures of Wistar and August rats was measured biochemically under normal conditions and after short-term exposure to delta-sleep-inducing peptide. pmid-16758612
- Animal study, rats, 2003: The membranotropic effect of DSIP in the norm and under stress is connected to increase of stability of protein--lipid interplays. pmid-12635477
- Animal study, rabbits, 1998: Enzyme inhibitors, such as o-phenanthroline, ethylene-diaminetetraacetic acid (EDTA), dilucine, and sodium deoxycholate, could inhibit the degradation of DSIP to a certain extent in the skin homogenate. pmid-9876605
- Animal study, rats, 1993: In the present study, we examined whether delta sleep-inducing peptide (DSIP) was (1) secreted from neurons on depolarization and (2) degraded by membrane-associated peptidases. pmid-8474631
- Animal study, rats, dogs, 1987: The biostability of DSIP (delta sleep-inducing peptide) and two analogs in blood was investigated in order to determine if rates of inactivation contribute to variable effects in vivo. pmid-3628078
How DSIP was given
The route changes what a dose means. The same number given intravenously and subcutaneously is not the same exposure.
- Clinical trial, humans, n=15, 2014: administration by intranasal route reported. Treatment with deltalicin (daily dose of 0.0003 g of delta sleep-inducing peptide intranasally for two months) decreased the latent period and led to less pronounced depression of VEP amplitude in patients with diabetic retinopathy, and reduced the period… pmid-25739189
- Randomized controlled trial, humans, 2009: administration by intravenous route reported. The other 12 were randomly allocated to receive one of three intravenous bolus doses of DSIP (Clinalfa) at 25, 50 or 100 nmol kg(-1). pmid-19142086
- Clinical trial, humans, n=5, 1995: administration by intravenous route reported. DSIP (total doses of 3 and 4 mg, respectively, vs. placebo) was infused intravenously between 30 min prior to and 90 min after CRH injections. pmid-7777652
- Randomized controlled trial, humans, 1992: administration by intravenous route reported. In the afternoon before the 3rd, 4th and 5th night, half of the patients received intravenously 25 nmol/kg body weight DSIP, and half of the patients a glucose solution (placebo). pmid-1299794
- Randomized controlled trial, humans, 1989: administration by intravenous route reported. Eleven healthy male volunteers, ages 25-39 years, received a single dose of synthetic delta sleep-inducing peptide (DSIP) (25 nmol/kg BW) or saline intravenously in a randomized cross-over, double-blind study. pmid-2554357
- Controlled clinical trial, humans, 1987: administration by intravenous route reported. DSIP in a dose of 25 nmol/kg or a placebo was administered i.v. during four nights using a double-blind crossover design. pmid-3583493
Questions people ask
- How many units is 300 mcg of DSIP?
- It depends entirely on how the vial was reconstituted. In a 5 mg vial with 2 mL of diluent it is 12 units on a U-100 syringe; with 1 mL it is 6. The chart above gives the rest.
- Does adding more diluent waste the peptide?
- No. The mass in the vial does not change. More diluent spreads the same mass through more liquid, so each dose is a larger, easier-to-measure volume and the vial yields exactly as many doses as before.
- Why does this page not recommend a dose?
- Because a dose is a clinical decision rather than a division. It depends on why someone is taking something, what else they take and how their kidneys and liver are working, none of which is knowable from a number typed into a box.
- Where do the doses in the table come from?
- Each is quoted from a specific paper indexed in Europe PMC, linked in the source column, and labelled with the kind of study it came from. The full evidence is on the DSIP record.
What this calculator will not do
It will not take a body weight and return a milligram figure, and it will not tell you how often to draw. The table above is the published record, not a menu. A dose that appeared in a trial appeared under supervision, with monitoring, in people selected for that trial.
Other calculators
- Generic reconstitution calculatorThe same arithmetic, without a compound attached
- Unit convertermg, mcg, ng and syringe units
- Vial plannerDraws per vial and how long it lasts
- All compound calculatorsEvery compound with published dose figures